There are so many game-changers on the horizon that sometimes it’s difficult to keep up.
Artificial intelligence. Self-driving cars. Virtual reality. Breakthroughs in energy storage. All of these can upend the status quo and change our daily lives for the better.
But cannabis, the plant from which marijuana is derived, is in a class by itself.
It already exists.
We have the compound in a useful form. It doesn’t need enhancements, tweaks, or new formulations. Its potential simply needs to be unleashed.
I’m not talking about recreational pot, where people try to decide if they’d like to smoke, vape, or chew an edible to get high.
I’m talking about medical marijuana, which has burst on the scene just as our nation is about to feel the crush of caring for a rapidly aging population.
The demand for legal marijuana is here, it’s growing, and it will continue to rise.
As more states allow medical and recreational use of marijuana, we’ll analyze more data on how consumers can use the substance to improve their health. Consumers will change their buying patterns, creating winners and losers, and it’s all starting right now.
With greater utilization of medical marijuana, patients will find more relief and spend less than they would on expensive prescription drugs. This growth could more than double the number of jobs in an industry that already employs about 150,000 people.
It’s fascinating to watch a fresh industry grow, thrive, and offer an entire generation a viable pain remedy alternative … but is it enough to justify buying stock in a marijuana-related company right now?
In our latest infographic Is the Grass Getting Greener?, we dive deeper into these issues, and take a closer look at some of the numbers that could help or hinder the growth of marijuana as a practical investment opportunity.
There’s no question medical marijuana is an industry on the rise, but what roadblocks could be keeping investors on the sidelines… and what related opportunities are currently presenting themselves?
The content of our articles is based on what we’ve learned as financial journalists. We do not offer personalized investment advice: you should not base investment decisions solely on what you read here. It’s your money and your responsibility. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments such as futures, options, and currency trading carry large potential rewards but also large potential risk. Don’t trade in these markets with money you can’t afford to lose. Delray Publishing LLC expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers.
Recommended Content
Editors’ Picks
EUR/USD stays near 1.0800 after upbeat US data
EUR/USD stays under modest bearish pressure and trades near 1.0800 in the American session on Thursday. The data from the US showed that the real GDP growth for the fourth quarter got revised higher to 3.4% from 3.2%, supporting the USD and weighing on the pair.
GBP/USD stays in daily range above 1.2600
GBP/USD fluctuates in a narrow channel above 1.2600 on Thursday. The better-than-expected Initial Jobless Claims data from the US and the upward revision to the Q4 GDP growth helps the USD stay resilient against its rivals and limits the pair's upside.
Gold pulls away from daily highs, holds above $2,200
Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Thursday. The benchmark 10-year US Treasury bond yield stays above 4.2% after upbeat US data and makes it difficult for XAU/USD to preserve its bullish momentum.
XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC
XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase.
Portfolio rebalancing and reflation trades emerge into Q2
Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.